High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myelomaBruno Paiva, Jesús F. San Miguel, Norma C. Gutiérrez et al.|Blood|2011Cited by 304
Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell–Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric PatientsAntonio Pérez‐Martínez, Cristina Díaz de Heredia, Adela Escudero et al.|Transplantation and Cellular Therapy|2018Cited by 56
A Prospective, Multicenter, Randomized, Trial of Bortezomib/Melphalan/Prednisone (VMP) Versus Bortezomib/Thalidomide/Prednisone (VTP) as Induction Therapy Followed by Maintenance Treatment with Bortezomib/Thalidomide (VT) Versus Bortezomib/Prednisone (VP) in Elderly Untreated Patients with Multiple Myeloma Older Than 65 Years.María‐Victoria Mateos, Jesús F. San Miguel, Albert Oriol et al.|Blood|2009Cited by 45
Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood TransplantationJaime Sanz, Guillermo Sanz, Alessandra Picardi et al.|Transplantation and Cellular Therapy|2013Cited by 26
Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia PatientsBeatriz Colom-Fernández, Cecilia Muñoz‐Calleja, Anna Kreutzman et al.|Frontiers in Pharmacology|2019Cited by 15